Related references
Note: Only part of the references are listed.Nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells
Jonathan D. Silk et al.
JOURNAL OF IMMUNOLOGY (2008)
CD1d ligands: The good, the bad and the ugly
Randy R. Brutkiewicz
JOURNAL OF IMMUNOLOGY (2006)
Quantitative and qualitative differences in the in vivo response of NKT cells to distinct α- and β-anomeric glycolipids
VV Parekh et al.
JOURNAL OF IMMUNOLOGY (2004)
Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy
JD Silk et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells
S Oki et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Going both ways: immune regulation via CD1d-dependent NKT cells
DI Godfrey et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells
IF Hermans et al.
JOURNAL OF IMMUNOLOGY (2003)
Share Paper
